The Latest Cardiac and Vascular News
LAS VEGAS, Sept. 12, 2017 /PRNewswire-USNewswire/ — VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 20 highly anticipated late-breaking clinical trial results on Tuesday morning at VIVA 17, hosted at the Wynn Las Vegas. Below are highlights […]
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase the product portfolio recently acquired from its new subsidiary, Vascular Solutions, as well as its Arrow® Hemodialysis, Oncology and Peripheral Intervention Solutions at the CIRSE Congress being held in […]
SUNNYVALE, Calif.–(BUSINESS WIRE)–A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ DETOUR System for treating long-segment (>25 cm) blockages in the femoropopliteal artery. The data were presented as a late breaking clinical trial session today at Vascular InterVentional Advances (VIVA 17) […]
DUBLIN and LAS VEGAS – September 12, 2017 – Medtronic plc (NYSE: MDT) data announced today reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD). The two-year, real-world results from the full clinical cohort of the IN.PACT Global Study and four-year […]
MINNETONKA, Minn., Sept. 12, 2017 /PRNewswire/ — IMRIS, the global leader in intraoperative imaging, recently celebrated its two-year anniversary under new ownership with strong financial growth and strategic investments for continued future success. Through a reorganization and the backing of parent company Deerfield Management in August 2015, IMRIS emerged under a new LLC, brand, […]
NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that its Board of Directors has approved the voluntary delisting from NASDAQ. As a result of the shareholder non-approval of its reverse stock […]
Approval of CE Mark paves the way for application expansion and the exploration of new therapeutic areas for ground-breaking surgical solutions. Paris, France, September 11, 2017 – Gecko Biomedical (“Gecko”), a medical device company developing innovative polymers to support tissue reconstruction, announced today that it has received CE Mark approval […]
PENANG, 11 April 2016 – Expanding its manufacturing footprint in the Asia Pacific region, Boston Scientific Corporation (NYSE: BSX) today marked the commencement of construction work on a regional manufacturing hub during a groundbreaking ceremony in Penang. Located at the Batu Kawan Industrial Park, the completion of the facility is planned […]
DUBLIN, Ireland, September 12, 2017 /PRNewswire/ — Vasorum Ltd, following FDA approval of its PMA supplement, the developer and manufacturer of the novel Celt ACD®vascular closure device has added a 7F sized Celt ACD® device to its Celt ACD® 6F and Celt ACD® 5F size range in the USA. Celt ACD® is indicated for arterial puncture closure in […]
VANCOUVER, Sept. 12, 2017 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX: NVCN) today provided an update on the study progress and clinical performance of the TiaraTM valve, a self-expanding mitral bioprosthesis for transcatheter implantation in patients with Mitral Regurgitation (“MR”), one of the most prevalent valvular heart diseases in western […]
